Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia
Leuk Lymphoma
.
2024 Dec;65(14):2228-2230.
doi: 10.1080/10428194.2024.2397570.
Epub 2024 Sep 4.
Authors
Kellen B Gil
1
,
Diana Abbott
2
,
Maria L Amaya
1
,
Marc Schwartz
1
,
Jonathan A Gutman
1
,
Andrew Kent
1
,
Grace Bosma
2
,
Daniel A Pollyea
1
,
Christine M McMahon
1
Affiliations
1
University of Colorado School of Medicine, Denver, CO, USA.
2
Center for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado, Denver, CO, USA.
PMID:
39229898
DOI:
10.1080/10428194.2024.2397570
No abstract available